Observations on angiopoietin 2 in patients with angiosarcoma

被引：17

作者：

Amo, Y ^{[1
]}

Masuzawa, M ^{[1
]}

Hamada, Y ^{[1
]}

Katsuoka, K ^{[1
]}

机构：

[1] Kitasato Univ, Sch Med, Dept Dermatol, Kanagawa 2288555, Japan

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2004年 / 150卷 / 05期

关键词：

D O I：

10.1111/j.1365-2133.2004.05932.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 [皮肤病与性病学];

摘要：

引用

页码：1028 / 1029

页数：2

共 8 条

[1]

Serum levels of vascular endothelial growth factor in a haemangiosarcoma patient with a newly typed p53 gene point mutation [J].

Amo, Y ;

Masuzawa, M ;

Hamada, Y ;

Takasu, H ;

Fujimura, T ;

Katsuoka, K ;

Tamauchi, H .

BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (05) :1118-1119

[2]

Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation [J].

Amo, Y ;

Masuzawa, M ;

Hamada, Y ;

Katsuoka, K .

ACTA DERMATO-VENEREOLOGICA, 2002, 82 (05) :373-374

[3]

Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS) [J].

Amo, Y ;

Masuzawa, M ;

Hamada, Y ;

Katsuoka, K .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2001, 293 (06) :296-301

[4]

Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo [J].

Lobov, IB ;

Brooks, PC ;

Lang, RA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11205-11210

[5]

Masuzawa M, 1999, INT J CANCER, V81, P305, DOI 10.1002/(SICI)1097-0215(19990412)81:2<305::AID-IJC22>3.0.CO

[6]

2-Z

[7]

Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin [J].

Sarlos, S ;

Rizkalla, B ;

Moravski, CJ ;

Cao, ZM ;

Cooper, ME ;

Wilkinson-Berka, JL .

AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (03) :879-887

[8]

Zhang L, 2003, CANCER RES, V63, P3403

← 1 →